Cargando…

Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism

BACKGROUND: We examine the clinical significance and biomarkers of tissue plasminogen activator (tPA)-catalyzed clot lysis time (CLT) in patients with intermediate-risk pulmonary embolism (PE). METHODS: Platelet-poor, citrated plasma was obtained from patients with PE. Healthy age- and sex-matched p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stubblefield, William B., Alves, Nathan J., Rondina, Matthew T., Kline, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751085/ https://www.ncbi.nlm.nih.gov/pubmed/26866684 http://dx.doi.org/10.1371/journal.pone.0148747

Ejemplares similares

Plasminogen Receptors and Fibrinolysis
por: Miles, Lindsey A., et al.
Publicado: (2021)

Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism
por: Zhang, Ling-Yun, et al.
Publicado: (2018)

Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis
por: Berri, Fatma, et al.
Publicado: (2013)

Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?
por: Roncon, Loris, et al.
Publicado: (2020)

Reduced-Dose Systemic Fibrinolysis in Massive Pulmonary Embolism: A Pilot Study
por: Aykan, Ahmet Çağrı, et al.
Publicado: (2023)

Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics
por: Elhakim, Abdelrahman, et al.
Publicado: (2022)

Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis
por: Wang, Hong, et al.
Publicado: (2016)

Intermediate-High Risk Pulmonary Embolism
por: Mirambeaux, Rosa, et al.
Publicado: (2019)

Ixonnexin from Tick Saliva Promotes Fibrinolysis by Interacting with Plasminogen and Tissue-Type Plasminogen Activator, and Prevents Arterial Thrombosis
por: Assumpção, Teresa C., et al.
Publicado: (2018)

Clinical variables that increase the probability of pulmonary embolism diagnosis in symptomatic children
por: Hennelly, Kara E., et al.
Publicado: (2019)

Plasminogen
por: Kline, Daniel L.
Publicado: (1954)

Rescue fibrinolysis in suspected massive pulmonary embolism during SARS-CoV-2 pandemic
por: Ly, André, et al.
Publicado: (2020)

Intermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration
por: Weekes, Anthony J., et al.
Publicado: (2022)

A Novel Serine Protease Secreted by Medicinal Maggots Enhances Plasminogen Activator-Induced Fibrinolysis
por: van der Plas, Mariena J. A., et al.
Publicado: (2014)

Plasminogen activator inhibitor‐1 augments damage by impairing fibrinolysis after traumatic brain injury
por: Griemert, Eva‐Verena, et al.
Publicado: (2019)

Intermediate pulmonary embolism: Diagnosis and management
por: Davidson, Bruce L
Publicado: (2019)

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies
por: Longstaff, Colin, et al.
Publicado: (2011)

Correction: A Novel Serine Protease Secreted by Medicinal Maggots Enhances Plasminogen Activator-Induced Fibrinolysis
Publicado: (2014)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

Tissue Plasminogen Activator Use in Cardiac Arrest Secondary to Fulminant Pulmonary Embolism
por: Yousuf, Tariq, et al.
Publicado: (2016)

Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism
por: Gulati, Vishal, et al.
Publicado: (2018)

Fibrinolysis: an illustrated review
por: Risman, Rebecca A., et al.
Publicado: (2023)

Tissue Plasminogen Activator–Mediated Fibrinolysis Protects against Axonal Degeneration and Demyelination after Sciatic Nerve Injury
por: Akassoglou, Katerina, et al.
Publicado: (2000)

Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor
por: Ito, Yusuke, et al.
Publicado: (2018)

Unchanging Mortality from Pulmonary Embolism in the United States
por: Sung, Yon K., et al.
Publicado: (2023)

Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management
por: Machanahalli Balakrishna, Akshay, et al.
Publicado: (2022)

One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism
por: Piazza, Gregory, et al.
Publicado: (2020)

FIBRINOLYSIS ASSOCIATED WITH ONCOGENIC TRANSFORMATION : REQUIREMENT OF PLASMINOGEN FOR CORRELATED CHANGES IN CELLULAR MORPHOLOGY, COLONY FORMATION IN AGAR, AND CELL MIGRATION
por: Ossowski, L., et al.
Publicado: (1973)

The plasminogen receptor, Plg-R(KT), plays a role in inflammation and fibrinolysis during cutaneous wound healing in mice
por: Ny, Lina, et al.
Publicado: (2020)

Pulmonary vasodilation in acute pulmonary embolism – a systematic review
por: Lyhne, Mads Dam, et al.
Publicado: (2020)

Cardiovascular Ultrasound in the Diagnosis and Management of Acute Intermediate-Risk Pulmonary Embolism
por: Fabijanic, Damir, et al.
Publicado: (2012)

Pulmonary artery catheter-directed thrombolysis for intermediate high risk acute pulmonary embolism
por: Singh, Abhijeet, et al.
Publicado: (2017)

Differential effect of mild and severe pulmonary embolism on the rat lung transcriptome
por: Zagorski, John, et al.
Publicado: (2016)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism
por: Patel, Darshan C., et al.
Publicado: (2019)

Alterations of coagulation and fibrinolysis in patients with blunt splenic injury after splenic artery embolization
por: Ren, Chuanzeng, et al.
Publicado: (2021)

Pharmacological Fibrinolysis
por: Fearnley, G. R.
Publicado: (1969)

Efficacy and safety of hydro-mechanical defragmentation in intermediate- and high-risk pulmonary embolism
por: Hassan, Ayman K. M., et al.
Publicado: (2021)

Changing biventricular mechanics during thrombectomy for intermediate high-risk pulmonary embolism
por: van den Enden, Antoon J M, et al.
Publicado: (2022)

The PENUMBRA Lightning 12 system for treatment of acute intermediate-high pulmonary embolism. Initial experience in Pulmonary Circulation Center Krakow, Poland
por: Stępniewski, Jakub, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bfh9cd26sivm429s1glinfj2pm